{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:37:53Z","timestamp":1791549473783,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["2016\/07866-1"],"award-info":[{"award-number":["2016\/07866-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer is a multifactorial disease caused by uncontrolled proliferation of cells. About 50\u201380% of cancer patients develop cachexia, a complex metabolic syndrome associated with an increase of mortality and morbidity. However, there are no effective therapies in medical clinic for cancer cachexia. <jats:italic>Vochysia tucanorum<\/jats:italic> Mart. is a common three of the Brazilian \u201cCerrado\u201d. The butanolic fraction of <jats:italic>V. tucanorum<\/jats:italic> (Fr-BuVt), very rich in triterpenes with various biological activities, might be interesting in being tested in cancer cachexia syndrome. Hence, the present study was undertaken to investigate the antitumoral activity of Fr-BuVt and its potential against cachexia development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ehrlich tumor was used as model of cancer cachexia. Ascitic Ehrlich tumor cells were collected, processed and inoculated subcutaneously in saline solution (1\u2009\u00d7\u200910<jats:sup>7<\/jats:sup>\/100\u2009\u03bcl; \u226595% viability) for the obtention of solid Ehrlich carcinoma. After inoculation, solid Ehrlich carcinoma-bearing mice were treated by 14 consecutive days by gavage with Fr-BuVt (200\u2009mg\/kg). Body weight and tumor volume were measure during the treatment period. Tumors were removed, weighed and properly processed to measure the content and phosphorylation levels of key-proteins involved to apoptotic and proliferation process by Western Blot. Muscles and adipose tissues were removed for weighed. Serum was collected to cytokines levels and energetic blood markers measurements.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The treatment with the Fr-BuVt (200\u2009mg\/kg, 14\u2009days) decreased the solid Ehrlich tumor volume and weight besides increased the expression of the pro-apoptotic proteins caspase-3 and BAX, but also decreased the expression of the proteins involved in proliferation NF\u03baB, mTOR and ERK. In addition, our data shows that the administration of Fr-BuVt was able to prevent the installation of cancer cachexia in Ehrlich carcinoma-bearing mice, since prevented the loss of body weight, as well as the loss of muscle and adipose tissue. Moreover, an improvement in some blood parameters such as decrease in cytokines TNF-\u03b1 and IL-6 levels is observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study revealed that Fr-BuVt has antitumoral activity and prevent installation of cancer cachexia in Ehrlich model. Therefore, Fr-BuVt may represent an alternative treatment for cancer cachexia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-020-03190-1","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T14:03:57Z","timestamp":1610028237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vochysia tucanorum Mart. butanol fraction presents antitumoral activity in vivo and prevents the installation of cachexia in solid Ehrlich tumor model"],"prefix":"10.1186","volume":"21","author":[{"given":"Henrique Jorge Novaes","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aislan Quintiliano","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Leonardo","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia Aparecida De Paula","family":"Camaforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L\u00edgia","family":"Dokkedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5367-7427","authenticated-orcid":false,"given":"Jos\u00e9 Roberto","family":"Bosqueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3190_CR1","first-page":"630","volume-title":"World Cancer Report 2014","author":"WHO","year":"2014","unstructured":"WHO. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. 1st ed. Lyon: International Agency for Research on Cancer; 2014. p. 630. Available from: http:\/\/publications.iarc.fr\/Non-Series-Publications\/World-Cancer-Reports\/World-Cancer-Report-2014.","edition":"1"},{"issue":"5","key":"3190_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia : an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3190_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of Cancer Cachexia. Physiol Rev. 2009;89(2):381\u2013410.","journal-title":"Physiol Rev"},{"issue":"2","key":"3190_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10(2):90\u20139.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3190_CR5","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5(2):e200.","journal-title":"Oncogenesis"},{"issue":"18","key":"3190_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","volume":"50","author":"A Loumaye","year":"2017","unstructured":"Loumaye A, Thissen J-P. Biomarkers of cancer cachexia. Clin Biochem. 2017;50(18):1281\u20138.","journal-title":"Clin Biochem"},{"issue":"3","key":"3190_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/medicines2030251","volume":"2","author":"M Wink","year":"2015","unstructured":"Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251\u201386.","journal-title":"Medicines"},{"key":"3190_CR8","unstructured":"Gomes R de C, Bonamin F, Darin DD, Seito LN, Di SLC, Dokkedal AL, et al. Antioxidative action of methanolic extract and buthanolic fraction of Vochysia tucanorum Mart. In the gastroprotection. J Ethnopharmacol. 2009;121(3):466\u201371."},{"issue":"2","key":"3190_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0031-9422(79)80109-0","volume":"18","author":"JLC Lopes","year":"1979","unstructured":"Lopes JLC, Lopes JNC, Leitao Filho HF. 5-Deoxyflavones from the Vochysiaceae. Phytochemistry. 1979;18(2):362.","journal-title":"Phytochemistry"},{"issue":"4","key":"3190_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.drudis.2013.07.018","volume":"19","author":"X-J Yan","year":"2014","unstructured":"Yan X-J, Gong L-H, Zheng F-Y, Cheng K-J, Chen Z-S, Shi Z. Triterpenoids as reversal agents for anticancer drug resistance treatment. Drug Discov Today. 2014;19(4):482\u20138.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3190_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12906-016-1397-1","volume":"16","author":"A Romero-Estrada","year":"2016","unstructured":"Romero-Estrada A, Maldonado-Maga\u00f1a A, Gonz\u00e1lez-Christen J, Bahena SM, Gardu\u00f1o-Ram\u00edrez ML, Rodr\u00edguez-L\u00f3pez V, et al. Anti-inflammatory and antioxidative effects of six pentacyclic triterpenes isolated from the Mexican copal resin of Bursera copallifera. BMC Complement Altern Med. 2016;16(1):422.","journal-title":"BMC Complement Altern Med"},{"key":"3190_CR12","doi-asserted-by":"crossref","unstructured":"Reyes-Zurita FJ, Rufino-Palomares EE, Garc\u00eda-Salguero L, Perag\u00f3n J, Medina PP, Parra A, et al. Maslinic acid, a natural triterpene, induces a death receptor-mediated apoptotic mechanism in caco-2 p53-deficient colon adenocarcinoma cells. L\u00f3pez Lluch G, editor. PLoS One. 2016;11(1):e0146178.","DOI":"10.1371\/journal.pone.0146178"},{"issue":"4","key":"3190_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/np1007922","volume":"74","author":"N Zeng","year":"2011","unstructured":"Zeng N, Shen Y, Li L-Z, Jiao W-H, Gao P-Y, Song S-J, et al. Anti-inflammatory Triterpenes from the leaves of Rosa laevigata. J Nat Prod. 2011;74(4):732\u20138.","journal-title":"J Nat Prod"},{"issue":"3","key":"3190_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.tiv.2009.12.008","volume":"24","author":"YS Lei","year":"2010","unstructured":"Lei YS, Yin HC, Tzy WS, Chin YM. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol Vitr. 2010;24(3):842\u20138.","journal-title":"Toxicol Vitr"},{"issue":"41","key":"3190_CR15","doi-asserted-by":"publisher","first-page":"26370","DOI":"10.18632\/oncotarget.25316","volume":"9","author":"GJ Kim","year":"2018","unstructured":"Kim GJ, Jo HJ, Lee KJ, Choi JW, An JH. Oleanolic acid induces p53-dependent apoptosis via the ERK\/ JNK\/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice. Oncotarget. 2018;9(41):26370\u201386.","journal-title":"Oncotarget"},{"issue":"1","key":"3190_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1872213X10666160711143904","volume":"10","author":"D Kashyap","year":"2016","unstructured":"Kashyap D, Sharma A, Tuli HS, Punia S, Sharma AK. Ursolic acid and Oleanolic acid: Pentacyclic Terpenoids with promising anti-inflammatory activities. Recent Patents Inflamm Allergy Drug Discov. 2016;10(1):21\u201333.","journal-title":"Recent Patents Inflamm Allergy Drug Discov"},{"key":"3190_CR17","doi-asserted-by":"crossref","unstructured":"Sharma H, Kumar P, Deshmukh RR, Bishayee A, Kumar S. Pentacyclic triterpenes: new tools to fight metabolic syndrome. Phytomedicine. 2018;50:166\u201377.","DOI":"10.1016\/j.phymed.2018.09.011"},{"key":"3190_CR18","doi-asserted-by":"crossref","unstructured":"Bashir R. Ursolic acid and maslinic acid: novel candidates for counteracting muscle loss and improving body composition. In: Bagchi D, Nair S, Sen CK eds. Nutrition and enhanced sports performance. London; Academic Press; 2019. pp. 707\u201314.","DOI":"10.1016\/B978-0-12-813922-6.00061-8"},{"issue":"6","key":"3190_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/obr.12523","volume":"18","author":"CK Katashima","year":"2017","unstructured":"Katashima CK, Silva VR, Gomes TL, Pichard C, Pimentel GD. Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review. Obes Rev. 2017;18(6):700\u201311.","journal-title":"Obes Rev"},{"key":"3190_CR20","first-page":"78","volume":"1","author":"P Ehrlich","year":"1906","unstructured":"Ehrlich P. Experimental Carcinoma Study. Arb Inst Exp Ther Frankfurt. 1906;1:78\u201380.","journal-title":"Arb Inst Exp Ther Frankfurt"},{"issue":"9","key":"3190_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1055\/s-0034-1370967","volume":"46","author":"NM Violato","year":"2014","unstructured":"Violato NM, Rafacho A, Boschero AC, Bosqueiro JR. Higher insulin sensitivity and impaired insulin secretion in cachetic solid ehrlich tumour-bearing mice. Horm Metab Res. 2014;46(9):615\u201320.","journal-title":"Horm Metab Res"},{"issue":"1","key":"3190_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2015.12.004","volume":"372","author":"VV Costantino","year":"2016","unstructured":"Costantino VV, Lobos-Gonzalez L, Iba\u00f1ez J, Fernandez D, Cuello-Carri\u00f3n FD, Valenzuela MA, et al. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis. Cancer Lett. 2016;372(1):10\u201323.","journal-title":"Cancer Lett"},{"key":"3190_CR23","doi-asserted-by":"crossref","unstructured":"Camaforte NADP, Saldanha LL, Vareda PMP, Rezende-Neto JM, Senger MR, Delgado AQ, et al. Hypoglycaemic activity of Bauhinia holophylla through GSK3-\u03b2 inhibition and glycogenesis activation. Pharm Biol. 2019;57(1):269\u201379.","DOI":"10.1080\/13880209.2019.1599962"},{"issue":"1","key":"3190_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-2275(20)39633-4","volume":"6","author":"K Itaya","year":"1965","unstructured":"Itaya K, Ui M. Colorimetric determination of free fatty acids in biological fluids. J Lipid Res. 1965;6(1):16\u201320.","journal-title":"J Lipid Res"},{"issue":"5","key":"3190_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1139\/Y07-037","volume":"85","author":"A Rafacho","year":"2007","unstructured":"Rafacho A, Roma LP, Taboga SR, Boschero AC, Bosqueiro JR. Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets. Can J Physiol Pharmacol. 2007;85(5):536\u201345.","journal-title":"Can J Physiol Pharmacol"},{"issue":"11\u201312","key":"3190_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1365\/s10337-006-0087-4","volume":"64","author":"ALM Nasser","year":"2006","unstructured":"Nasser ALM, Mazzolin LP, Hiruma-Lima CA, Santos LS, Eberlin MN, Souza Brito ARM, et al. Preparative droplet counter-current chromatography for the separation of the new nor-Seco-Triterpene and Pentacyclic Triterpenoids from Qualea parviflora. Chromatographia. 2006;64(11\u201312):695\u20139.","journal-title":"Chromatographia"},{"issue":"1","key":"3190_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ptr.1613","volume":"19","author":"B Weniger","year":"2005","unstructured":"Weniger B, Lobstein A, Um B-H, Vonthron-S\u00e9n\u00e9chau C, Anton R, Usuga NJ, et al. Bioactive triterpenoids from Vochysia pacifica interact with cyclic nucleotide phosphodiesterase isozyme PDE4. Phyther Res. 2005;19(1):75\u20137.","journal-title":"Phyther Res"},{"key":"3190_CR28","doi-asserted-by":"crossref","unstructured":"Carnevale Neto F, Pilon AC, Silva DHS, da Silva Bolzani V, Castro-Gamboa I. Vochysiaceae: secondary metabolites, ethnopharmacology and pharmacological potential. Phytochem Rev 2011;10(3):413\u2013429.","DOI":"10.1007\/s11101-011-9213-5"},{"key":"3190_CR29","first-page":"507","volume-title":"Medicinal natural products : a biosynthetic approach","author":"PM Dewick","year":"2002","unstructured":"Dewick PM. In: Dewick PM, editor. Medicinal natural products : a biosynthetic approach. 2nd ed. Chichester, England: John Wiley & Sons, Ltd; 2002. p. 507.","edition":"2"},{"key":"3190_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0015-6264(65)80209-7","volume":"3","author":"R Schoental","year":"1965","unstructured":"Schoental R. Toxicology of natural products. Food Cosmet Toxicol. 1965;3:609\u201320.","journal-title":"Food Cosmet Toxicol"},{"issue":"1\u20132","key":"3190_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/01480549709011077","volume":"20","author":"C Toskulkac","year":"1997","unstructured":"Toskulkac C, Chaturat L, Temcharoen P, Glinsukon T. Acute toxicity of Stevioside, a natural sweetener, and its metabolite, Steviol, in several animal species. Drug Chem Toxicol. 1997;20(1\u20132):31\u201344.","journal-title":"Drug Chem Toxicol"},{"key":"3190_CR32","first-page":"1","volume":"2017","author":"F Li","year":"2017","unstructured":"Li F, Li Y, Li Q, Shi X, Guo Y. Acute and subacute Oral toxicity evaluation of Eriobotrya japonica leaf Triterpene acids in ICR mice. Evid based Complement Altern Med. 2017;2017:1\u20139.","journal-title":"Evid based Complement Altern Med"},{"key":"3190_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/543606","volume":"2014","author":"PMP Vareda","year":"2014","unstructured":"Vareda PMP, Saldanha LL, Camaforte NADP, Violato NM, Dokkedal AL, Bosqueiro JR. Myrcia bella leaf extract presents hypoglycemic activity via PI3k\/Akt insulin signaling pathway. Evid Based Complement Altern Med. 2014;2014:1\u201311.","journal-title":"Evid Based Complement Altern Med"},{"issue":"1","key":"3190_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mnfr.200700491","volume":"53","author":"S Fulda","year":"2009","unstructured":"Fulda S. Betulinic acid: a natural product with anticancer activity. Mol Nutr Food Res. 2009;53(1):140\u20136.","journal-title":"Mol Nutr Food Res"},{"issue":"53","key":"3190_CR35","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1038\/sj.onc.1207107","volume":"22","author":"A Degterev","year":"2003","unstructured":"Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22(53):8543\u201367.","journal-title":"Oncogene"},{"issue":"1","key":"3190_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall M, Rodriguez-Menocal L, De Guevara R, Cepero E, Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013;14(1):32.","journal-title":"BMC Cell Biol"},{"issue":"9","key":"3190_CR37","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007;26(9):1324\u201337.","journal-title":"Oncogene"},{"issue":"2","key":"3190_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3835(02)00593-1","volume":"190","author":"J Fernandes","year":"2003","unstructured":"Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K, Coelho Kaplan MA, Gattass CR. Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett. 2003;190(2):165\u20139.","journal-title":"Cancer Lett"},{"issue":"11","key":"3190_CR39","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1021\/np020105a","volume":"65","author":"G Gaidi","year":"2002","unstructured":"Gaidi G, Tomofumi M, Laurens V, Lacaille-Dubois M-A. New Acylated Triterpene Saponins from Silene fortunei that modulate lymphocyte proliferation. J Nat Prod. 2002;65(11):1568\u201372.","journal-title":"J Nat Prod"},{"issue":"4","key":"3190_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2014.02.004","volume":"35","author":"S-C Wang","year":"2014","unstructured":"Wang S-C. PCNA: a silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci. 2014;35(4):178\u201386.","journal-title":"Trends Pharmacol Sci"},{"issue":"December","key":"3190_CR41","first-page":"1","volume":"8","author":"Z-Q Lai","year":"2017","unstructured":"Lai Z-Q, Ip S-P, Liao H-J, Lu Z, Xie J-H, Su Z-R, et al. Brucein D, a naturally occurring tetracyclic Triterpene quassinoid, induces apoptosis in pancreatic Cancer through ROS-associated PI3K\/Akt signaling pathway. Front Pharmacol. 2017;8(December):1\u201315.","journal-title":"Front Pharmacol"},{"key":"3190_CR42","doi-asserted-by":"crossref","unstructured":"Checker R, Sandur SK, Sharma D, Patwardhan RS, Jayakumar S, Kohli V, et al. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-\u03baB, AP-1 and NF-AT. Bob\u00e9 P, editor. PLoS One. 2012;7(2):e31318.","DOI":"10.1371\/journal.pone.0031318"},{"key":"3190_CR43","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-\u03baB in development and progression of human cancer. Virchows Arch. 2005;446:475\u201382.","journal-title":"Virchows Arch"},{"issue":"3","key":"3190_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/07853890600551037","volume":"38","author":"M Kohno","year":"2006","unstructured":"Kohno M, Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann Med. 2006;38(3):200\u201311.","journal-title":"Ann Med"},{"issue":"48","key":"3190_CR45","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","volume":"25","author":"JB Easton","year":"2006","unstructured":"Easton JB, Houghton PJ. mTOR and cancer therapy. Oncogene. 2006;25(48):6436\u201346.","journal-title":"Oncogene."},{"issue":"2","key":"3190_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tips.2014.11.004","volume":"36","author":"F Chiarini","year":"2015","unstructured":"Chiarini F, Evangelisti C, McCubrey JA, Martelli AM. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci. 2015;36(2):124\u201335.","journal-title":"Trends Pharmacol Sci"},{"key":"3190_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lfs.2016.08.009","volume":"162","author":"FTT Frajacomo","year":"2016","unstructured":"Frajacomo FTT, de Souza Padilha C, Marinello PC, Guarnier FA, Cecchini R, JAR D, et al. Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia. Life Sci. 2016;162:47\u201353.","journal-title":"Life Sci"},{"issue":"10","key":"3190_CR48","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","volume":"45","author":"S Ciciliot","year":"2013","unstructured":"Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol. 2013;45(10):2191\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"3190_CR49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1188\/02.ONF.517-532","volume":"29","author":"JK Brown","year":"2002","unstructured":"Brown JK. A systematic review of the evidence on symptom management of Cancer-related anorexia and Cachexia. Oncol Nurs Forum. 2002;29(3):517\u201332.","journal-title":"Oncol Nurs Forum"},{"key":"3190_CR50","doi-asserted-by":"crossref","unstructured":"Patel HJ, Patel BM. TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications. Life Sciences. 2017;170.","DOI":"10.1016\/j.lfs.2016.11.033"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-020-03190-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:06:15Z","timestamp":1610053575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-020-03190-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3190"],"URL":"https:\/\/doi.org\/10.1186\/s12906-020-03190-1","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol approval letter was obtained from the Ethics Committee on Animal Experiments (CEUA) of School of Sciences, S\u00e3o Paulo State University and registered as protocol number 526\/2017 vol.1, on May 01, 2017.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}